Miramoon Pharma

Spin-off of the University of the Basque Country and Biogipuzkoa Health Research Institute. Focused on developing First in Class drugs for Neurodegenerative and Rare Diseases. First program in lead optimisation for Retinitis Pigmentosa (RP), and four programs in lead nomination for DMD, DM1, ALS and... Read more